Di Bono, R. v. Santore, L.

CourtSuperior Court of Pennsylvania
DecidedJune 3, 2026
Docket2524 EDA 2024
StatusUnpublished
AuthorLane

This text of Di Bono, R. v. Santore, L. (Di Bono, R. v. Santore, L.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Di Bono, R. v. Santore, L., (Pa. Ct. App. 2026).

Opinion

J-A10021-26

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT O.P. 65.37

ROSS DI BONO AND LUCILLE DI : IN THE SUPERIOR COURT OF BONO, H/W : PENNSYLVANIA : Appellants : : : v. : : : No. 2524 EDA 2024 LOUIS X. SANTORE, M.D. :

Appeal from the Judgment Entered August 20, 2024 In the Court of Common Pleas of Philadelphia County Civil Division at No(s): 220100261

BEFORE: STABILE, J., LANE, J., and STEVENS, P.J.E.*

MEMORANDUM BY LANE, J.: FILED JUNE 3, 2026

Ross Di Bono (“Ross”) and Lucille Di Bono, husband and wife

(collectively “the Di Bonos”), appeal from the judgment entered in favor of

Louis X. Santore, M.D. (“Dr. Santore”) in this medical malpractice action.

After careful review, we affirm.

The trial court summarized the relevant factual and procedural history

of this matter as follows:

[I]n December . . . 2020, [Dr. Santore] diagnosed . . . Ross . . . with a cataract in his right eye and recommended that [he] come in for surgery on January 7, 2021. Prior to the operation, [Dr. Santore] wrote a pre-operative order to [Ross’] medical care providers instructing them to review [Dr. Santore’s] post- operative care sheet with [Ross]. This sheet also contained post- operative instructions for [Ross]. [Dr. Santore] also sent a prescription for antibiotic eye drops with detailed instructions on their application to [Ross’] pharmacy, which [Ross] received. ____________________________________________

* Former Justice specially assigned to the Superior Court. J-A10021-26

On the day of the surgery, [Dr. Santore] encountered a complication in removing the final quadrant of [Ross’] lens that allowed vitreous material to enter the anterior chamber of the right eye. Testimony during trial from both parties confirmed that such complications can occur in the absence of negligently performed medical care. However, it may also place a patient at a higher risk of infection. Once [Dr. Santore] noticed the complication, he ceased surgery and began making arrangements for [Ross] to see a retinal specialist. [Dr. Santore] contacted Mid- Atlantic Retina from the operating room, specifically hoping to connect with Dr. Omesh Gupta [(“Dr. Gupta”)] so that he could immediately refer [Ross] to him. [Dr. Santore] spoke . . . with Dr. Gupta thereafter, arranging for [Ross] to visit Dr. Gupta for evaluation that same day, January 7, 2021.

During their post-operative consultation on January 7, [Dr. Santore] orally conveyed to [Ross] that he should avoid taking the prescribed antibiotic eye drops until receiving Dr. Gupta’s examination and recommendations. [Dr. Santore] had the understanding that he had fully transferred care to Dr. Gupta, therefore[,] he did not schedule a follow-up visit in the days following the surgery. Typically, such a [follow-up] visit, alongside the administration of antibiotic eye drops, would be necessary in order to catch and/or prevent infection, such as endophthalmitis. Dr. Gupta instructed [Ross] to continue the use of the eye drops following their visit, but [Ross] admitted that he did not administer the eye drops for three days following the surgery. Eventually, [Ross] developed endophthalmitis in his right eye, [as well as uveitis and retinal detachment, necessitating additional surgeries, and] resulting in loss of vision and use of his eye.

[The Di Bonos] initiated the current action in January 2022, [against, inter alia, Dr. Santore, Dr. Gupta, and Mid-Atlantic Retina.] [T]he case proceeded to [a] jury trial [solely against Dr. Santore] on June 6, 2024. [At trial, the Di Bonos presented the testimony of Robert D. Fechtner, M.D. (“Dr. Fechtner”), who testified that Dr. Santore deviated from the standard of care, particularly with respect to his procedures in patient handoff, lack of post-operative communication, and instructing Ross to not use the prescribed antibiotic eyedrops. Dr. Fechtner opined that these deviations in the standard of care substantially contributed to Ross’ endophthalmitis. Conversely, Dr. Santore and his medical

-2- J-A10021-26

expert, Michael E. Sulewski, M.D. (“Dr. Sulewski”), both testified that not only did Dr. Santore not deviate from the standard of care in patient handoff procedures, but that endophthalmitis can occur even if a patient is taking antibiotic eyedrops. Dr. Sulewski did not concede that Ross suffered endophthalmitis. Dr. Sulewski did not dispute that Ross suffered uveits and retinal detachment, but he attributed these conditions to Ross’ delay in using the antibiotic eyedrops. Notably, Dr. Gupta testified that, during his January 7, 2021 appointment with Ross, he confirmed that Ross had obtained the antibiotic eyedrops that Dr. Santore had prescribed, and he specifically instructed Ross to use the antibiotic eyedrops that Dr. Santore had prescribed. Additionally, Ross testified at trial that he failed to use the antibiotic eyedrops for the three days following the aborted cataract surgery.] At the conclusion of trial, the jury returned a verdict in favor of [Dr. Santore], finding that while he had acted negligently in breaching the standard of care, this conduct was not the factual cause of the harm suffered by [the Di Bonos]. . . .

Trial Court Opinion, 7/17/25, at 1-3, 7-8.

The Di Bonos filed a timely post-trial motion in which they argued that

the verdict was against the weight of the evidence and requested the entry of

judgment notwithstanding the verdict (“JNOV”) in their favor on the issues of

negligence and causation, and a new trial on damages only. In the alternative,

they requested a new trial on the issues of causation and damages, or in the

alternative, a new trial on all issues. The trial court denied the motion. The

Di Bonos thereafter filed a timely notice of appeal. The trial court did not

order them to file a concise statement of errors complained of on appeal

pursuant to Pa.R.A.P. 1925(b). Upon directive from this Court, the trial court

authored an opinion pursuant to Rule 1925(a).

The Di Bonos raise the following issue for our review: “Whether the trial

court abused its discretion in refusing to grant a new trial when the weight of

-3- J-A10021-26

the evidence indicates that Dr. . . . Santore[’s] negligence was a factual cause

of . . . Ross[’] injuries.” Di Bonos’ Brief at 4. 1

Our standard of review in this area is well settled and extremely limited:

The decision whether to grant or deny a new trial based on the weight of the

evidence is one that lies within the discretion of the trial court and will not be

overturned unless the court grossly abused its discretion or committed an

error of law which controlled the outcome of the case. See Turney Media

Fuel, Inc. v. Toll Bros., 725 A.2d 836, 841 (Pa. Super. 1999). The weight

to be accorded to the evidence and testimony presented at trial is exclusively

for the finder of fact, who is free to believe all, part, or none of the evidence

and to determine the credibility of the witnesses. See Brown v. Trinidad,

111 A.3d 765, 770 (Pa. Super. 2015). A new trial based on weight of the

evidence issues will not be granted unless the verdict is so contrary to the

evidence as to shock one’s sense of justice. See Cangemi v. Cone, 774 A.2d

1262, 1265 (Pa. Super. 2000). An appellant is not entitled to a new trial

where the evidence is conflicting, and the finder of fact could have decided

either way. See id.

____________________________________________

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Andrews v. Jackson
800 A.2d 959 (Superior Court of Pennsylvania, 2002)
Turney Media Fuel, Inc. v. Toll Bros., Inc.
725 A.2d 836 (Superior Court of Pennsylvania, 1999)
Cangemi Ex Rel. Estate of Cangemi v. Cone
774 A.2d 1262 (Superior Court of Pennsylvania, 2001)
Winschel v. Jain
925 A.2d 782 (Superior Court of Pennsylvania, 2007)
Holland v. Zelnick
478 A.2d 885 (Supreme Court of Pennsylvania, 1984)
Daniel v. William R. Drach Co., Inc.
849 A.2d 1265 (Superior Court of Pennsylvania, 2004)
Sundlun v. Shoemaker
617 A.2d 1330 (Superior Court of Pennsylvania, 1992)
Corvin, J. v. Tihansky, D.
184 A.3d 986 (Superior Court of Pennsylvania, 2018)
Koziar, M. v. Rayner, N.
200 A.3d 513 (Superior Court of Pennsylvania, 2018)
In re Mampe
932 A.2d 954 (Superior Court of Pennsylvania, 2007)
Brown v. Trinidad
111 A.3d 765 (Superior Court of Pennsylvania, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Di Bono, R. v. Santore, L., Counsel Stack Legal Research, https://law.counselstack.com/opinion/di-bono-r-v-santore-l-pasuperct-2026.